Albert Macaire C Ong Lopez1, Charles Jeffrey L Tan2, Antonio S Yabon2, Armin N Masbang3. 1. Department of Internal Medicine, St. Luke's Medical Center-Quezon City, 279 E Rodriguez Sr. Ave, Quezon City, 1112, Metro Manila, Philippines. macaire014@gmail.com. 2. Department of Internal Medicine, St. Luke's Medical Center-Quezon City, 279 E Rodriguez Sr. Ave, Quezon City, 1112, Metro Manila, Philippines. 3. Department of Internal Medicine, Section of Infectious Disease, St. Luke's Medical Center-Quezon City, 279 E Rodriguez Sr. Ave, Quezon City, 1112, Metro Manila, Philippines.
Abstract
BACKGROUND: Current guidelines recommend empiric antibiotics as first-line treatment for uncomplicated UTI. Despite proven benefits in treatment, antibiotic resistance rates remain on the rise. This meta-analysis aims to determine whether non-steroidal anti-inflammatory drugs can serve as an effective and safe option in the treatment of uncomplicated lower UTI among non-pregnant women compared to antibiotics. METHODS: A systematic literature search in PUBMED, CENTRAL, and ACP databases from inception to April 2021 was conducted to identify randomized controlled trials that compare the use of non-steroidal anti-inflammatory drugs versus antibiotics in non-pregnant women ≥18 years old with uncomplicated lower urinary tract infection. Primary outcomes were symptom resolution of UTI by Day 3 or 4 of intervention, and upper UTI complications. Secondary outcomes include persistence of positive urine culture despite treatment and need for another rescue antibiotic. Random and fixed-effects model for dichotomous data using Mantel-Haenszel and Peto odds method were reported at 95% CI followed by sensitivity analysis for substantial heterogeneity. RESULTS: Four RCTs involving 1165 patients were analyzed. The probability of having a symptom resolution by Day 3 or 4 with NSAID use is only less than three-fourths of that with antibiotic treatment (RR: 0.69, 95% CIs [0.55, 0.86], p = 0.0008, I2 = 73%, moderate certainty of evidence). The odds of developing upper UTI complications with use of NSAIDs are 6.49 to 1 for antibiotics (Peto OR: 6.49, 95% CIs [3.02, 13.92], p < 0.00001, I2 = 0%, moderate certainty of evidence). Secondary analysis showed that the NSAID group is 2.77x more likely to have persistence of a positive microbiologic urine culture than the antibiotic group (RR: 2.77, 95% CIs [1.95, 3.94], p < 0.00001, I2 = 36%, moderate certainty of evidence). Treatment with NSAIDs are three times more likely to use a secondary or rescue antibiotic due to persistent or worsening symptoms as compared to antibiotics (RR: 3.16, 95% CIs [2.24, 4.44], p < 0.00001, I2 = 47%, low certainty of evidence). CONCLUSION: Antibiotic treatment was more effective than use of non-steroidal anti-inflammatory drugs for acute uncomplicated lower urinary tract infection with an overall moderate certainty of evidence.
BACKGROUND: Current guidelines recommend empiric antibiotics as first-line treatment for uncomplicated UTI. Despite proven benefits in treatment, antibiotic resistance rates remain on the rise. This meta-analysis aims to determine whether non-steroidal anti-inflammatory drugs can serve as an effective and safe option in the treatment of uncomplicated lower UTI among non-pregnant women compared to antibiotics. METHODS: A systematic literature search in PUBMED, CENTRAL, and ACP databases from inception to April 2021 was conducted to identify randomized controlled trials that compare the use of non-steroidal anti-inflammatory drugs versus antibiotics in non-pregnant women ≥18 years old with uncomplicated lower urinary tract infection. Primary outcomes were symptom resolution of UTI by Day 3 or 4 of intervention, and upper UTI complications. Secondary outcomes include persistence of positive urine culture despite treatment and need for another rescue antibiotic. Random and fixed-effects model for dichotomous data using Mantel-Haenszel and Peto odds method were reported at 95% CI followed by sensitivity analysis for substantial heterogeneity. RESULTS: Four RCTs involving 1165 patients were analyzed. The probability of having a symptom resolution by Day 3 or 4 with NSAID use is only less than three-fourths of that with antibiotic treatment (RR: 0.69, 95% CIs [0.55, 0.86], p = 0.0008, I2 = 73%, moderate certainty of evidence). The odds of developing upper UTI complications with use of NSAIDs are 6.49 to 1 for antibiotics (Peto OR: 6.49, 95% CIs [3.02, 13.92], p < 0.00001, I2 = 0%, moderate certainty of evidence). Secondary analysis showed that the NSAID group is 2.77x more likely to have persistence of a positive microbiologic urine culture than the antibiotic group (RR: 2.77, 95% CIs [1.95, 3.94], p < 0.00001, I2 = 36%, moderate certainty of evidence). Treatment with NSAIDs are three times more likely to use a secondary or rescue antibiotic due to persistent or worsening symptoms as compared to antibiotics (RR: 3.16, 95% CIs [2.24, 4.44], p < 0.00001, I2 = 47%, low certainty of evidence). CONCLUSION: Antibiotic treatment was more effective than use of non-steroidal anti-inflammatory drugs for acute uncomplicated lower urinary tract infection with an overall moderate certainty of evidence.
Entities:
Keywords:
Antibiotics; NSAIDS; Non-steroidal anti-inflammatory drugs; Symptomatic treatment; Uncomplicated UTI
Authors: Andrew I Geller; Maribeth C Lovegrove; Nadine Shehab; Lauri A Hicks; Mathew R P Sapiano; Daniel S Budnitz Journal: J Gen Intern Med Date: 2018-04-20 Impact factor: 5.128
Authors: T C M Christiaens; M De Meyere; G Verschraegen; W Peersman; S Heytens; J M De Maeseneer Journal: Br J Gen Pract Date: 2002-09 Impact factor: 5.386
Authors: M Moore; J Trill; C Simpson; F Webley; M Radford; L Stanton; T Maishman; A Galanopoulou; A Flower; C Eyles; M Willcox; A D Hay; E van der Werf; S Gibbons; G Lewith; P Little; G Griffiths Journal: Clin Microbiol Infect Date: 2019-01-25 Impact factor: 8.067
Authors: Carmen Ka Man Wong; Kenny Kung; Philip Lung Wai Au-Doung; Margaret Ip; Nelson Lee; Alice Fung; Samuel Yeung Shan Wong Journal: PLoS One Date: 2018-02-23 Impact factor: 3.240
Authors: Helena Owusu; Pruthu Thekkur; Jacklyne Ashubwe-Jalemba; George Kwesi Hedidor; Oksana Corquaye; Asiwome Aggor; Allen Steele-Dadzie; Daniel Ankrah Journal: Int J Environ Res Public Health Date: 2022-09-29 Impact factor: 4.614